Marex Group »

Nurix Therapeutics shares owned by Marex Group

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Marex Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $340k 14k 24.26

More positions owned by Marex Group

Sandisk Corp Call Option (SNDK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom Put Option (AVGO)
Microsoft Corporation Put Option (MSFT)
Applied Optoelectronics Put Option (AAOI)
Ast Spacemobile Com Cl A Call Option (ASTS)
Marvell Technology (MRVL)
Lumentum Hldgs Put Option (LITE)
Eli Lilly & Co. Put Option (LLY)
NVIDIA Corporation Put Option (NVDA)
UnitedHealth Put Option (UNH)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors Call Option (TSLA)
Axt (AXTI)
Space Exploration Techn Corp Class A Com Stk (SPCX)

View all positions for Marex Group

Top funds holding Nurix Therapeutics

BlackRock
Vestal Point Capital
Deep Track Capital
Rubric Capital Management
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
Perceptive Advisors
Redmile Group
T. Rowe Price Associates
General Atlantic
Geode Capital Management
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics